Beijing Chunlizhengda Medical Instruments Co Ltd Asset Resilience Ratio
Beijing Chunlizhengda Medical Instruments Co Ltd asset resilience ratio. Beijing Chunlizhengda Medical Instruments Co Ltd (688236) has an Asset Resilience Ratio of 25.01% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Beijing Chunlizhengda Medical Instrument (688236) liquidity interval to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Beijing Chunlizhengda Medical Instruments Co Ltd (2012–2024)
Asset resilience ratio of Beijing Chunlizhengda Medical Instruments Co Ltd from 2012 to 2024. This chart shows how Beijing Chunlizhengda Medical Instruments Co Ltd's Asset Resilience Ratio has changed over time. Read total liabilities of Beijing Chunlizhengda Medical Instrument for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Beijing Chunlizhengda Medical Instruments Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Beijing Chunlizhengda Medical Instrument total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥885.47 Million | 25.01% |
| Total Liquid Assets | CN¥885.47 Million | 25.01% |
Asset Resilience Insights
- Very High Liquidity: Beijing Chunlizhengda Medical Instruments Co Ltd maintains exceptional liquid asset reserves at 25.01% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Beijing Chunlizhengda Medical Instruments Co Ltd Industry Peers by Asset Resilience Ratio
Compare Beijing Chunlizhengda Medical Instruments Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Shanghai Sanyou Medical Co Ltd
SHG:688085 |
Medical Devices | 7.69% |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607 |
Medical Devices | 16.21% |
|
Cleo Diagnostics Ltd
AU:COV |
Medical Devices | 94.64% |
|
Memphasys Ltd
AU:MEM |
Medical Devices | 0.00% |
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
Beijing Chunlizhengda Medical Instruments Co Ltd Asset Resilience Ratio by Year (2012–2024)
Beijing Chunlizhengda Medical Instruments Co Ltd asset resilience ratio by year from 2012 to 2024. The table below shows the annual Asset Resilience Ratio data for Beijing Chunlizhengda Medical Instruments Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 21.52% | CN¥745.80 Million ≈ $109.13 Million |
CN¥3.47 Billion ≈ $507.15 Million |
-1.28pp |
| 2023-12-31 | 22.80% | CN¥832.02 Million ≈ $121.75 Million |
CN¥3.65 Billion ≈ $534.05 Million |
+0.28pp |
| 2022-12-31 | 22.52% | CN¥767.73 Million ≈ $112.34 Million |
CN¥3.41 Billion ≈ $498.96 Million |
-35.37pp |
| 2021-12-31 | 57.89% | CN¥1.74 Billion ≈ $254.10 Million |
CN¥3.00 Billion ≈ $438.94 Million |
+13.08pp |
| 2020-12-31 | 44.81% | CN¥690.12 Million ≈ $100.99 Million |
CN¥1.54 Billion ≈ $225.35 Million |
+12.17pp |
| 2012-12-31 | 32.64% | CN¥61.21 Million ≈ $8.96 Million |
CN¥187.51 Million ≈ $27.44 Million |
-- |
About Beijing Chunlizhengda Medical Instruments Co Ltd
Beijing Chunlizhengda Medical Instruments Co., Ltd. engages in the research and development, production, and trading of surgical implants, instruments, and related products in the People's Republic of China. The company offers implantable orthopedic medical devices, joints, dentures, spine, sports medicine, trauma and orthopedic surgical instruments. It sells its products through distributors, or… Read more